Get started
Author

Maryam Norouzbahari

ORCID: 0000-0002-6187-7055
Observed ORCID: 0000-0002-6187-7055
OpenAlex ID: A5078593802
Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase
2021 · Fariba Peytam, Ghazaleh Takalloobanafshi, et al. · Scientific Reports · 81
PDF
Design, synthesis, and biological evaluation of 1-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea derivatives as anticancer agents
2020 · Ayoub Aghcheli, Mahsa Toolabi, et al. · Medicinal Chemistry Research · 29
Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety
2020 · Maryam Norouzbahari, Somayeh Salarinejad, et al. · DARU Journal of Pharmaceutical Sciences · 27
Design, Synthesis and Characterization of Novel Urolithin Derivatives as Cholinesterase Inhibitor Agents
2018 · Maryam Norouzbahari, Emine V. Burgaz, et al. · Letters in Drug Design & Discovery · 23
Design, synthesis, and evaluation of novel substituted imidazo[1,2-c]quinazoline derivatives as potential α-glucosidase inhibitors with bioactivity and molecular docking insights
2024 · Fariba Peytam, Faezeh Sadat Hosseini, et al. · Scientific Reports · 18
Design, synthesis, and evaluation of triazolo[1,5-a]pyridines as novel and potent α‑glucosidase inhibitors
2025 · Fariba Peytam, Parham Foroumadi, et al. · Scientific Reports · 11
PDF
Identification of novel triazolopyrimidines as potent α-glucosidase inhibitor through design, synthesis, biological evaluations, and computational analysis
2025 · Fariba Peytam, Maryam Norouzbahari, et al. · Scientific Reports · 10
PDF
New coumarin–chalcone–triazole hybrids as promising anti-diabetic agents: from molecular design to in vivo validation
2025 · Fariba Peytam, Maryam Norouzbahari, et al. · RSC Advances · 9
PDF
Design, synthesis, and antidiabetic evaluation of triazolopyrimidine thioacetamides as potent and selective α-glucosidase inhibitors
2026 · Fariba Peytam, Maryam Norouzbahari, et al. · Bioorganic Chemistry · 5
Novel fluoroquinolones analogues bearing 4-(arylcarbamoyl)benzyl: design, synthesis, and antibacterial evaluation
2023 · Fariba Peytam, Maryam Norouzbahari, et al. · Molecular Diversity · 5
Potent and selective α-glucosidase inhibition by coumarin–triazole conjugates: design, in vivo evaluation, and computational insights
2026 · Mahdis Sadeghi Moghadam, Bahareh Bayati, et al. · RSC Advances · 2
PDF
Novel imidazo[1,2-a]pyridine-based α-glucosidase inhibitors: synthesis, biological evaluations, and computational studies
2026 · Maryam Norouzbahari, Zahra Emamgholipour, et al. · Scientific Reports · 1
PDF
Design, synthesis, and biological evaluation of novel triazolopyrimidine–1,2,3-triazole–acetamide hybrids as potent α-glucosidase inhibitors supported by in silico studies
2026 · Fariba Peytam, Mahmood Biglar, et al. · Scientific Reports
PDF
Aniline-linked coumarin–triazole hybrids as α-glucosidase inhibitors: An insightful study from synthesis to in vivo efficacy and mechanistic analysis
2026 · Bahareh Bayati, Mahdis Sadeghi Moghadam, et al. · Bioorganic Chemistry
Exploring Novel Nitrofuryl‐1,3,4‐Thiadiazole‐Based Derivatives: Design, Synthesis, and Evaluation of In Vitro Leishmanicidal and Trypanocidal Activity
2026 · Alireza Mousavi, Martina Slapničková, et al. · Archiv der Pharmazie
Synthesis of a Novel Fluorescent Optical pH Sensor
2011 · Maryam Norouzbahari · Eastern Mediterranean University Institutional Repository (Eastern Mediterranean University)
PDF
Works count: 17
Citation count: 221
H-index: 8
I10-index: 7
Year
Topic
Type